南新制药(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688189 南新制药

已收盘 11-22 15:00:01

{"stockData":{"symbol":"688189","market":"SH","secType":"STK","nameCN":"南新制药","latestPrice":7.28,"timestamp":1732258801000,"preClose":7.74,"halted":0,"volume":7213376,"delay":0,"floatShares":274000000,"shares":274000000,"eps":-0.2505,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.46,"latestTime":"11-22 15:00:01","open":7.74,"high":7.82,"low":7.28,"amount":54072300,"amplitude":0.0698,"askPrice":7.28,"askSize":301,"bidPrice":7.27,"bidSize":183,"shortable":0,"etf":0,"ttmEps":-0.2505,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":7.74,"symbolType":"stock_kcb","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":8.51,"lowLimit":6.97,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":274400000,"pbRate":1.62,"roa":"--","roe":"--","epsLYR":0.0137,"committee":-0.437463,"marketValue":1998000000,"floatMarketCap":1998000000,"peRate":-29.061877,"changeRate":-0.0594,"turnoverRate":0.0263,"status":1,"afterMarket":{"amount":0,"volume":0,"close":7.28,"buyVolume":0,"sellVolume":0,"time":1732260839464,"indexStatus":"已收盘 11-22 15:30:00","preClose":7.74}},"requestUrl":"/m/hq/s/688189/wiki","defaultTab":"wiki","newsList":[{"id":"2485412622","title":"南新制药（688189）11月22日主力资金净卖出1382.73万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485412622","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485412622?lang=zh_cn&edition=full","pubTime":"2024-11-23 08:24","pubTimestamp":1732321479,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月22日收盘，南新制药报收于7.28元，下跌5.94%，换手率2.63%，成交量7.21万手，成交额5407.23万元。近5日资金流向一览见下表：南新制药融资融券信息显示，融资方面，当日融资买入667.98万元，融资偿还519.09万元，融资净买入148.89万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112300006519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2485424883","title":"核心产品以价换量难挽颓势 南新制药拟转让子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2485424883","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485424883?lang=zh_cn&edition=full","pubTime":"2024-11-23 03:51","pubTimestamp":1732305085,"startTime":"0","endTime":"0","summary":"2024年，南新制药再次对部分核心产品的销售价格进行下调。拟转让长期亏损子公司常德臻诚注册成立于2020年12月24日，主要业务是药品销售。对于此次交易的目的，南新制药方面表示，本次对外转让全资子公司常德臻诚100%股权，有利于优化公司资源配置，提高整体运营效率，降低运营成本，聚焦公司主业，提升公司综合实力，符合公司的整体发展战略。2023年，南新制药营业收入为7.44亿元，归属于母公司所有者的净利润为355万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123061940abd84ad8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123061940abd84ad8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2485837382","title":"南新制药大跌 资金净流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2485837382","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485837382?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:01","pubTimestamp":1732255295,"startTime":"0","endTime":"0","summary":"11月22日，南新制药股价大幅下跌，截至14点01分，南新制药下跌5.68%，报7.30元/股，成交4125万元，换手率1.99%，振幅6.72%。资金动向截止发稿，南新制药获得主力净流出1213万元，其中超大单流出1036万元，大单流出176万元。主营业务及业绩南新制药公司主营业务为专注于流行性感冒等抗病毒、传染病防治药品，以及心脑血管疾病、糖尿病等其他重大疾病治疗药品研发、生产与销售的制药企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122140147a24d1729&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122140147a24d1729&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2484695058","title":"南新制药：逐步降低帕拉米韦氯化钠注射液市场价，有利于巩固市场占有率","url":"https://stock-news.laohu8.com/highlight/detail?id=2484695058","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484695058?lang=zh_cn&edition=full","pubTime":"2024-11-19 12:03","pubTimestamp":1731988985,"startTime":"0","endTime":"0","summary":"11月19日，南新制药举办2024年第三季度业绩说明会。还有投资者询问，帕拉米韦注射液竞品上市后，公司持续采用低价策略，是否对市场占有率提高产生积极作用。对此，管理层回复，随着帕拉米韦氯化钠注射液的市场竞争逐渐激烈，公司逐步降低该产品的市场价格，该举有利于巩固市场占有率。针对目前院外市场的拓展情况，以及除帕拉米韦之外其他产品表现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119120414a244a334&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119120414a244a334&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2483834424","title":"南新制药(688189.SH)拟公开挂牌转让常德臻诚100%股权 提高整体运营效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2483834424","media":"智通财经网","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483834424?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:33","pubTimestamp":1731663222,"startTime":"0","endTime":"0","summary":"南新制药(688189.SH)公告，公司拟通过湖南省联合产权交易所有限公司(简称“...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/astock/10.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/10.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2483442533","title":"南新制药最新公告：拟公开挂牌转让全资子公司常德臻诚100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2483442533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483442533?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:30","pubTimestamp":1731663042,"startTime":"0","endTime":"0","summary":"南新制药公告，公司拟通过湖南联交所公开挂牌转让全资子公司常德臻诚100%股权。本次交易完成后，常德臻诚将不再纳入公司合并报表范围。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500029590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2483342539","title":"南新制药：拟挂牌转让常德臻诚100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2483342539","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483342539?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:23","pubTimestamp":1731662591,"startTime":"0","endTime":"0","summary":"公司本次对外转让全资子公司常德臻诚100%股权，有利于优化公司资源配置，提高整体运营效率，降低运营成本，聚焦公司主业，提升公司综合实力，符合公司的整体发展战略。本次交易完成后，常德臻诚将不再纳入公司合并报表范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115173328abc42cd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115173328abc42cd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2482249871","title":"南新制药创1个月新高 获主力净流入412万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482249871","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482249871?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:46","pubTimestamp":1731293213,"startTime":"0","endTime":"0","summary":"11月11日，南新制药股价大幅上涨，截至10点46分，南新制药上涨5.31%，报8.33元/股，创近1个月新高，成交5326万元，换手率2.40%。资金动向截止发稿，南新制药获得主力净流入412万元，其中超大单流入54万元，大单流入357万元。融资融券方面，南新制药11月08日获得融资净买入652万元，当日该股融资余额为7475万元，当较前一日增加9.56%；该股融券余额为9万元，融券余量为1.12万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111104700abb46f0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111104700abb46f0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2480197730","title":"南新制药大幅上涨 获主力净流入209万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480197730","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480197730?lang=zh_cn&edition=full","pubTime":"2024-11-01 09:30","pubTimestamp":1730424609,"startTime":"0","endTime":"0","summary":"11月01日，南新制药股价大幅上涨，截至09点30分，南新制药上涨5.30%，报7.55元/股，成交540万元，换手率0.26%，振幅4.18%。资金动向截止发稿，南新制药获得主力净流入209万元，其中超大单流入225万元，大单流出15万元。最新财报显示，今年三季报，南新制药实现营业收入2.27亿元，同比减少59.69%，净利润为-7,183.61万元，同比减少11142.92%，基本每股收益为-0.26元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101093035ab8eb3f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101093035ab8eb3f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2479746637","title":"南新制药(688189)9月30日股东户数0.91万户，较上期减少1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479746637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479746637?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:11","pubTimestamp":1730365880,"startTime":"0","endTime":"0","summary":"证券之星消息，近日南新制药披露，截至2024年9月30日公司股东户数为9069.0户，较6月30日减少153.0户，减幅为1.66%。在化学制药行业个股中，南新制药股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.1万户。从股价来看，2024年6月30日至2024年9月30日，南新制药区间涨幅为28.42%，在此期间股东户数减少153.0户，减幅为1.66%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100033802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2479781070","title":"南新制药(688189.SH)发布前三季度业绩，净亏损7184万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479781070","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479781070?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:25","pubTimestamp":1730298300,"startTime":"0","endTime":"0","summary":"南新制药(688189.SH)披露2024年第三季度报告，公司前三季度实现营收2.27亿元，同比下降59.69%;归母净利润亏损7184万元;扣非净利润亏损7235万元;基本每股收益-0.2623元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-30/doc-incukear6536061.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-30/doc-incukear6536061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688189"],"gpt_icon":0},{"id":"2479270413","title":"南新制药：公司上市以来，对募集项目的调整是基于市场环境变化和公司战略发展的综合考量","url":"https://stock-news.laohu8.com/highlight/detail?id=2479270413","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479270413?lang=zh_cn&edition=full","pubTime":"2024-10-30 19:00","pubTimestamp":1730286034,"startTime":"0","endTime":"0","summary":"证券之星消息，南新制药10月30日在投资者关系平台上答复投资者关心的问题。公司上市以来，对募集项目的调整是基于市场环境变化和公司战略发展的综合考量。近日央行明确将创设股票回购、增持专项再贷款，为上市公司和大股东提供资金支持。未来如有相关事项发生，公司将严格按照相关法律法规的要求履行信息披露义务。证监会“并购六条”发布以来，我们也一直密切关注着证券市场的动态变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000036620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2477130220","title":"南新制药：预挂牌转让全资子公司常德臻诚100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2477130220","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477130220?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:41","pubTimestamp":1729676460,"startTime":"0","endTime":"0","summary":"南新制药(688189)10月23日晚间公告，公司拟通过湖南省联合产权交易所有限公司，预挂牌转让公司全资子公司常德臻诚医药科技有限公司（简称“常德臻诚”）100%股权。常德臻诚的经营范围包括化学原料药及其制剂、抗生素原料药及其制剂、生化药品的批发等。 \n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-23/doc-inctpvrv7391297.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-23/doc-inctpvrv7391297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2477032413","title":"南新制药最新公告：拟预挂牌转让全资子公司常德臻诚100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2477032413","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477032413?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:21","pubTimestamp":1729675275,"startTime":"0","endTime":"0","summary":"南新制药公告，公司拟通过湖南省联合产权交易所有限公司预挂牌转让全资子公司常德臻诚医药科技有限公司100%股权。本次预挂牌仅为信息预披露，不构成交易行为，交易对方、交易价格、支付方式等交易主要内容目前尚无法确定，能否成交存在不确定性。本次交易预计不构成《上市公司重大资产重组管理办法》规定的重大资产重组事项。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300030469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2477303308","title":"南新制药(688189.SH)拟预挂牌转让常德臻诚100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2477303308","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477303308?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:18","pubTimestamp":1729675116,"startTime":"0","endTime":"0","summary":"智通财经APP讯，南新制药(688189.SH)发布公告，公司拟通过湖南省联合产权交易所有限公司预挂牌转让公司的全资子公司常德臻诚医药科技有限公司(简称“常德臻诚”)100%股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2477032293","title":"南新制药：预挂牌转让全资子公司100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2477032293","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477032293?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:17","pubTimestamp":1729675076,"startTime":"0","endTime":"0","summary":"格隆汇10月23日丨南新制药(688189.SH)公布，根据公司的整体经营规划和业务结构，结合行业发展情况，为进一步优化公司的管理架构、降低管理成本，提高整体运营效率，公司拟通过在湖南联交所公开挂牌转让的方式将全资子公司常德臻诚100%股权进行对外转让。按照国资监管的相关规定，本次交易在进行预挂牌后，还需进行正式挂牌，交易条件以正式挂牌为准。本次预挂牌后，公司将根据审计和评估情况履行相应审批程序后，进入正式挂牌程序。本次预挂牌仅为信息预披露，不构成交易行为，交易对方、交易价格、支付方式等交易主要内容目前尚无法确定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023171805ab6cc64f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023171805ab6cc64f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2476479448","title":"南新制药大幅上涨 多地支原体感染引发肺炎案例增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2476479448","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476479448?lang=zh_cn&edition=full","pubTime":"2024-10-18 14:42","pubTimestamp":1729233739,"startTime":"0","endTime":"0","summary":"10月18日，南新制药股价大幅上涨，截至14点42分，南新制药上涨5.15%，报7.15元/股，成交4291万元，换手率2.26%。消息解读近期，多地报道支原体感染引发肺炎案例增加，阿奇霉素、盐酸氨溴索等成为处方上的常客。主营业务及业绩南新制药公司主营业务为专注于流行性感冒等抗病毒、传染病防治药品，以及心脑血管疾病、糖尿病等其他重大疾病治疗药品研发、生产与销售的制药企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018154920ab6b16e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018154920ab6b16e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2476319898","title":"南新制药10月17日遭主力抛售79万元 环比增加887.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476319898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476319898?lang=zh_cn&edition=full","pubTime":"2024-10-17 15:18","pubTimestamp":1729149492,"startTime":"0","endTime":"0","summary":"10月17日，南新制药股价收平报6.80元，成交金额3333万元，换手率1.77%，振幅1.91%，量比0.82。南新制药今日主力资金净流出79万元，上一交易日主力净流出8万元，今日环比增加887.50%。|10月17日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|N托普云农|18.37%|#|凯旺科技|5.94%|#|国华网安|5.89%|#|华扬联众|4.41%|#|任子行|4.32%|#|中广天择|4.14%|#|捷邦科技|4.09%|#|工大科雅|3.99%|#|铭普光磁|3.74%|#|软通动力|3.71%|南新制药所在的化学制药行业，今日主力净流入1.42亿元，行业排名18/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101715291195aedd2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101715291195aedd2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2474305990","title":"南新制药大跌5.11% 主力资金净流出99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474305990","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474305990?lang=zh_cn&edition=full","pubTime":"2024-10-11 14:17","pubTimestamp":1728627435,"startTime":"0","endTime":"0","summary":"10月11日，南新制药股价大幅下跌，截至14点17分，南新制药下跌5.11%，报6.69元/股，成交3644万元，换手率1.94%。资金动向截止发稿，南新制药获得主力净流出99万元，其中超大单流出186万元，大单流入88万元。最新财报显示，今年中报，南新制药实现营业收入1.91亿元，同比减少62.86%，净利润为-444.75万元，同比减少115.66%，基本每股收益为-0.02元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011141832ab6956b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011141832ab6956b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688189","BK0239"],"gpt_icon":0},{"id":"2474646982","title":"南新制药大跌5.26% 融资净买入增加8.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474646982","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474646982?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:31","pubTimestamp":1728437484,"startTime":"0","endTime":"0","summary":"10月09日，南新制药股价大幅下跌，截至09点31分，南新制药下跌5.26%，报7.57元/股，成交419万元，换手率0.20%，振幅2.88%。资金动向截止发稿，南新制药获得主力净流出1099万元，其中超大单流出1189万元，大单流入90万元。融资融券方面，南新制药10月08日获得融资净买入441万元，当日该股融资余额为5897万元，当较前一日增加8.09%；该股融券余额为5万元，融券余量为0.68万股，比上日减少14.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009132835a1df49c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009132835a1df49c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-03-26","address":"湖南省长沙市浏阳市经济技术开发区康里路1号","stockEarnings":[{"period":"1week","weight":-0.028},{"period":"1month","weight":0.0125},{"period":"3month","weight":0.2423},{"period":"6month","weight":0.1269},{"period":"1year","weight":-0.3418},{"period":"ytd","weight":-0.228}],"companyName":"湖南南新制药股份有限公司","boardCode":"AI0027","perCapita":"30256股","boardName":"医药制造业","registeredCapital":"27440万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":"　　湖南南新制药股份有限公司专注于流行性感冒等抗病毒、传染病防治药品，以及恶性肿瘤、糖尿病等其他重大疾病治疗药品研发、生产与销售。主要产品是辛伐他汀分散片、帕拉米韦氯化钠注射液、乳酸环丙沙星氯化钠注射液、双赛普利、协诺信、保施泰等。公司创新药帕拉米韦氯化钠注射液开发项目获得国家“重大新药创制”科技专项支持,并成功入选国家“十二五”科技创新成就展,该产品已成为国家卫计委《流行性感冒诊疗方案(2018版)》的主要推荐药物之一,并列入国家应急产品目录。","serverTime":1732435675876,"listedPrice":34.94,"stockholders":"9069人(较上一季度减少1.66%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南新制药(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南新制药(688189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南新制药,688189,南新制药股票,南新制药股票老虎,南新制药股票老虎国际,南新制药行情,南新制药股票行情,南新制药股价,南新制药股市,南新制药股票价格,南新制药股票交易,南新制药股票购买,南新制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南新制药(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南新制药(688189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}